Results 331 to 340 of about 101,529 (354)
Some of the next articles are maybe not open access.

L-DOPA Cyclohexyl Ester Is a Novel Stable and Potent Competitive Antagonist Against L-DOPA, as Compared to L-DOPA Methyl Ester

The Japanese Journal of Pharmacology, 1997
Yoshio Goshima   +2 more
exaly  

Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia

Nature Neuroscience, 2003
B. Picconi   +7 more
semanticscholar   +1 more source

Some interactions of L-DOPA and its related compounds with glutamate receptors

Life Sciences, 1999
Yoshio Goshima, Takeaki Miyamae
exaly  

Process for L-dopa

1987
REINHOLD, DONALD F.   +2 more
openaire   +3 more sources

The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease

Pharmacological Reviews, 2013
P. Huot   +4 more
semanticscholar   +1 more source

Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

Journal of Pineal Research, 2006
Rossana Migheli   +2 more
exaly  

Interaction between l-DOPA and 3-O-methyl-l-DOPA for transport in immortalised rat capillary cerebral endothelial cells

Neuropharmacology, 1999
Pedro Gomes, Patricio Soares-Da-Silva
exaly  

Confronto fra L-Dopa + ID, Sec-Dopa e Sec-Dopa + ID (Fentiazac)

1978
S. Ruggeri   +6 more
openaire   +2 more sources

Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

Journal of Neurochemistry, 1993
Gabriel C Leger   +2 more
exaly  

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

European Journal of Nuclear Medicine and Molecular Imaging, 2014
F. Cicone   +8 more
semanticscholar   +1 more source
humans
dihydroxyphenylalanine
parkinson disease
dopamine
levodopa
female
3. good health
middle aged
l-dopa
previous   32  33  34  35  36  

Home - About - Disclaimer - Privacy